大会首页
关于大会
同期活动
演讲嘉宾
历届回顾
参展申请
展商中心
场馆介绍
联系我们
 
 
演讲嘉宾
 
孙乐博士
Biography (Times New Roman 10.5 font; between 600 and 1000 characters with space)
Dr. Sun, CEO & President of AbMax Biotechnology, Inc. Dr. Sun has more than 20 yrs experience in antibody-based cell signaling research and drug development. His team has generated monoclonal antibodies against over 500 different targets, many of them have been published in well-known journals. His team has been recognized by its clients as the best monoclonal antibody development company, selected as the preferred vendor for 15 top Pharmaceutical, Biotech companies and key research institutes in the world. Dr. Sun was Director of Research and Development at Upstate Biotechnology Inc., a market leader in the biotechnology research reagent s sector for cancer biology. His team introduced 200+ new antibodies and enzymes every year. Prior to that, he served as Director of Production at Upstate Biotechnology. Dr. Sun received his PhD in biochemistry/cell biology from Tsinghua University (Beijing). Dr. Sun spent two years as a postdoctoral fellow in Dr. David Barnes’s lab at Oregon State University, where he established primary cultures of zebrafish embryonic stem cells.
Since the outbreak in 2007, Hand-foot-mouth virus EV71 has taken thousands of life in China.  In collaboration with Chinese CDC and National Vaccine Engineering Center of China, we have successfully developed high quality monoclonal antibodies against EV71 within 35-days. One Sandwich ELISA kit has developed for the quality control of EV71 vaccine in collaboration with Chinese FDA. A monoclonal antibody with neutralization activity was also identified as potential drug lead.
第八届国际生物医药产业发展创新论坛